NaviFUS Corp. (¯E¦t¥ÍÂåªÑ¥÷¦³¤½¥q) Revenue and Competitors
Estimated Revenue & Valuation
- NaviFUS Corp. (¯E¦t¥ÍÂåªÑ¥÷¦³¤½¥q)'s estimated annual revenue is currently $4.3M per year.
- NaviFUS Corp. (¯E¦t¥ÍÂåªÑ¥÷¦³¤½¥q)'s estimated revenue per employee is $155,000
Employee Data
- NaviFUS Corp. (¯E¦t¥ÍÂåªÑ¥÷¦³¤½¥q) has 28 Employees.
- NaviFUS Corp. (¯E¦t¥ÍÂåªÑ¥÷¦³¤½¥q) grew their employee count by 8% last year.
NaviFUS Corp. (¯E¦t¥ÍÂåªÑ¥÷¦³¤½¥q) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is NaviFUS Corp. (¯E¦t¥ÍÂåªÑ¥÷¦³¤½¥q)?
NaviFUS is a Biotech company dedicated to providing novel platform solutions for crossing the blood-brain-barrier (BBB) for enhanced oncology drug delivery. Our product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. Our vision is to benefit CNS disease patients locally and globally by bringing break-through therapeutic ultrasound technology to clinical use through partnerships with global pharmaceutical companies.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Taipei City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7M | 28 | 0% | N/A |
#2 | $3.4M | 30 | 7% | N/A |
#3 | $4.1M | 37 | -5% | N/A |
#4 | $4.6M | 40 | N/A | N/A |
#5 | $4.9M | 42 | 2% | N/A |